Sam Chun Dang Pharm. Co., Ltd. (000250) Price & Analysis

― Followers

000250 Stock Chart & Stats

$158300.00

$8,700.00(5.82%)

Aug 03, 2026

―

Day’s Range― - ―

52-Week Range$120,000.00 - $1,233,000.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)N/A

Market Cap

₩3.48T

Enterprise Value$19.41M

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.60

Next Earnings

Aug 18, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)233.15

Shares Outstanding23,457,472

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

000250 FAQ

What was Sam Chun Dang Pharm. Co., Ltd.’s price range in the past 12 months?

Sam Chun Dang Pharm. Co., Ltd. lowest stock price was $120000.00 and its highest was $1233000.00 in the past 12 months.

What is Sam Chun Dang Pharm. Co., Ltd.’s market cap?

Sam Chun Dang Pharm. Co., Ltd.’s market cap is ₩3.48T.

When is Sam Chun Dang Pharm. Co., Ltd.’s upcoming earnings report date?

Sam Chun Dang Pharm. Co., Ltd.’s upcoming earnings report date is Aug 18, 2026 which is in 14 days.

How were Sam Chun Dang Pharm. Co., Ltd.’s earnings last quarter?

Sam Chun Dang Pharm. Co., Ltd. released its earnings results on May 15, 2026. The company reported $233.151 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Sam Chun Dang Pharm. Co., Ltd. overvalued?

According to Wall Street analysts Sam Chun Dang Pharm. Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Sam Chun Dang Pharm. Co., Ltd. pay dividends?

Sam Chun Dang Pharm. Co., Ltd. does not currently pay dividends.

What is Sam Chun Dang Pharm. Co., Ltd.’s EPS estimate?

Sam Chun Dang Pharm. Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Sam Chun Dang Pharm. Co., Ltd. have?

Sam Chun Dang Pharm. Co., Ltd. has 23,457,472 shares outstanding.

What happened to Sam Chun Dang Pharm. Co., Ltd.’s price movement after its last earnings report?

Sam Chun Dang Pharm. Co., Ltd. reported an EPS of $233.151 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.198%.

Which hedge fund is a major shareholder of Sam Chun Dang Pharm. Co., Ltd.?

Currently, no hedge funds are holding shares in KR:000250

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology